HIF3A

RNA & survival
SurvivalRNAKaplan–Meier · TCGA cohorts

Across TCGA pan-cancer cohorts, HIF3A RNA is linked to patient survival in 21 of 34 cancer types, making it the most broadly survival-associated HIF3A data layer compared with 13 for mutation status and 1 for mass-spec protein.

The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where higher HIF3A RNA is associated with worse overall survival. In most high-consensus cancer types, elevated HIF3A expression acts as an unfavorable survival marker, although some lineages such as UCS and HNSC show a favorable association.

UCEC, UCS, and HNSC are the cancer types where HIF3A RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.
LineageMeasureSplitStageAUC1
high
AUC2
low
pSampling consensus
UCECOSMedianAll0.6030.735<.00186view →
UCSDFSQuartileIII,IV0.8370.215<.00158view →
HNSCDFSQuartileIV0.4800.188<.00157view →
OVOSMedianAll0.7930.886.00452view →
ACCDFSTertileAll0.9010.409<.00150view →
THCAOSTertileAll0.8770.988.00236view →
SCLCDFSMedianII,III,IV0.1890.513.00325view →
BLCAOSMedianIV0.2370.556.01321view →
KIRPOSQuartileII,III,IV0.6650.910.02714view →
SARCDFSTertileAll0.7180.526.00612view →
UVMDFSTertileAll0.5350.927.01011view →
SKCMOSQuartileIII,IV0.8120.503.0137view →
Pink = unfavorable, green = favorable. Showing the 12 strongest of 21 lineages.

HIF3A–UCEC (OS)

Kaplan–Meier survival curve for HIF3A RNA-high vs -low samples in UCEC.

Open the UCEC breakdown →

Exploration